DFDA

Vitamin A Supplementation

Treatment for Measles

Typical Dosage: Oral; 50,000 IU (<6 mos), 100,000 IU (6-11 mos), 200,000 IU (>=1 year)

Effectiveness
80%
Safety Score
85%
Clinical Trials
1
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
Oral; 50,000 IU (<6 mos), 100,000 IU (6-11 mos), 200,000 IU (>=1 year)
Time to Effect
Within days
Treatment Duration
2 days (two doses)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
180(Treat 180 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0.1
Monitoring:$600
Side Effect Mgmt:$0
Total Annual:$600.1
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$500/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$0.12
Prescription Access EconomicsOTC Available
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
LOW
Vitamin A Supplementation Outcomes

for Measles

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Common Side Effects
Temporary headache
+10%
Nausea
+5%
Vomiting
+5%
Bulging fontanelle (infants)
+1%

Sources:

nih.gov
researchgate.net
cochrane.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov